100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Volledige samenvatting infectieziekten prof. De Munter $13.52   Add to cart

Summary

Volledige samenvatting infectieziekten prof. De Munter

 143 views  8 purchases
  • Course
  • Institution

Volledige samenvatting infectieziekten prof. De Munter. Geslaagd met glans in eerste zit.

Preview 5 out of 51  pages

  • September 16, 2022
  • 51
  • 2021/2022
  • Summary
avatar-seller
SV INFECTIEZIEKTEN

EXAMEN

• 1 open, grote vraag (ongeveer 1 hoofdstuk)
• 1 open vraag over de cursus heen vb bespreek klierkoorts
• 1 casus: DD en behandeling geven



Examen........................................................................................................................................................... 1

H1: Pathofysiologie van infectieziekten .......................................................................................................... 4
Definities ............................................................................................................................................................. 4
Pathofysiologie.................................................................................................................................................... 4
Microbiële virulentie ........................................................................................................................................... 5
Pathogenese van infecties .................................................................................................................................. 5
Afweermechanismen van de gastheer ................................................................................................................ 6

H2: Epidemiologie van infectieziekten ............................................................................................................ 8
Beschrijvende epidemiologie............................................................................................................................... 8
Surveillance ......................................................................................................................................................... 8

H3: Klinische aspecten en aanvullende diagnostiek van infectieziekten .......................................................... 9
Klinische aspecten ............................................................................................................................................... 9
Koorts .................................................................................................................................................................. 9
Aanvullende diagnostiek ................................................................................................................................... 11

H4: Sepsis ..................................................................................................................................................... 12
Definities ........................................................................................................................................................... 12
Etiologie ............................................................................................................................................................ 12
Pathogenese ..................................................................................................................................................... 13
Prognose ........................................................................................................................................................... 15
Behandeling ...................................................................................................................................................... 15
Bijzondere gevallen van sepsis .......................................................................................................................... 15

H5: Koorts bij terugkeer uit (sub)tropen........................................................................................................ 17

H6: Infectieuze diarree .................................................................................................................................. 19
Etiologie en pathogenese .................................................................................................................................. 19
Symptomen en diagnose ................................................................................................................................... 20



1

, Behandeling ...................................................................................................................................................... 20
Antibiotica-geassocieerde diarree .................................................................................................................... 20

H7: HIV en AIDS ............................................................................................................................................ 22
Epidemiologie.................................................................................................................................................... 22
Transmissie ....................................................................................................................................................... 22
Klinisch verloop ................................................................................................................................................. 22
Initiële evaluatie ................................................................................................................................................ 23
Klinische classificatie ......................................................................................................................................... 23
Behandeling en opvolging van de HIV patiënt .................................................................................................. 24
Preventie bij zorgverleners ................................................................................................................................ 26
Preventie bij niet-professionele risico’s ............................................................................................................. 26

H8: Seksueel overdraagbare aandoeningen (SOA) ......................................................................................... 27
Syphilis .............................................................................................................................................................. 27
Gonorree ........................................................................................................................................................... 27
Niet gonokokken urethritis................................................................................................................................ 28
Herpes genitalis................................................................................................................................................. 28
Condylomata accuminata ................................................................................................................................. 28
Algemene opmerkingen bij SOA ........................................................................................................................ 28

H9: Bacteriële infecties ................................................................................................................................. 29
Buiktyphus......................................................................................................................................................... 29
Non-typhi salmonellosen................................................................................................................................... 29
Bijtwonden ........................................................................................................................................................ 29
Leptospirose ...................................................................................................................................................... 30
KatteNkrabziekte .............................................................................................................................................. 30
Ziekte van Lyme ................................................................................................................................................ 31
Tetanus ............................................................................................................................................................. 32
Pertussis ............................................................................................................................................................ 32

H10: Virale infecties ...................................................................................................................................... 34
Influenza............................................................................................................................................................ 34
Mononucleosis infectiosa .................................................................................................................................. 34
Cytomegalovirus ............................................................................................................................................... 35
Herpes Simplex virus ......................................................................................................................................... 35
Varicella Zoster Virus ........................................................................................................................................ 36
Hantavirus ......................................................................................................................................................... 37
SARS/MERS ....................................................................................................................................................... 37
COVID-19 (SARS-CoV-2)..................................................................................................................................... 38



2

,H11: Fungale infecties ................................................................................................................................... 39
Candidase.......................................................................................................................................................... 39
Aspergillose ....................................................................................................................................................... 40

H12: Parasitaire infecties .............................................................................................................................. 41
Toxoplasmose ................................................................................................................................................... 41
Malaria.............................................................................................................................................................. 41

H13: Vaccinaties bij volwassenen .................................................................................................................. 42
Wie vaccineren? ................................................................................................................................................ 42
Basisvaccinatieschema...................................................................................................................................... 42
Tetanus-difterie ................................................................................................................................................. 42
Influenza............................................................................................................................................................ 43
Pneumokokken .................................................................................................................................................. 44
Hoe patiënten overtuigen ................................................................................................................................. 45
EXTRA: Asplenie ................................................................................................................................................ 45

H14: Rationele antimicrobiële therapie......................................................................................................... 46
Inleiding ............................................................................................................................................................ 46
Microbiologische basis van antibiotica therapie ............................................................................................... 46
Farmacologische basis van antimicrobiële therapie ......................................................................................... 49
Klinische basis van antimicrobiele therapie ...................................................................................................... 50




3

, H1: PATHOFYSIOLOGIE VAN INFECTIEZIEKTEN

DEFINITIES

Infectieziekte = klinisch waarneembare toestand van schade of verandering in de normale fysiologie
van de gastheer die gepaard gaat met een ontstekingsreactie (inflammatie), veroorzaakt door de
besmetting met een ziekmakend micro-organisme

Besmetting gaat infectie vooraf, maar leidt niet noodzakelijk tot infectie, soms is er enkel kolonisatie
(vb darmflora) of dragerschap (micro-organismen vermenigvuldigen zich, maar leiden niet tot
inflammatie of schade)

PATHOFYSIOLOGIE

Infectie als pathogeen vermogen van micro-organisme (virulentie) > afweermechanismen gastheer

PIRAMIDE VAN DE INFECTIEZIEKTEN : geeft interactie tussen micro-organisme en gastheer weer




Klinisch beeld wordt bepaald door ziekmakend vermogen vh micro-organisme en de infectiefocus
enerzijds en inflammatoire reactie van de gastheer anderzijds




4

, MICROBIËLE VIRULENTIE

Onderscheid op basis van ziekmakend vermogen van micro-organismen (virulentie)

PRIMAIR/OBLIGAAT PATHOGENE MICRO-ORGANISMEN
• Besmetting -> ziekte (meestal)
• Exogene infectie, overdraagbaar, kunnen leiden tot epidemie
• Salmonella typhi, mycobacterium tuberculosis, HIV, influenza, SARS-COV2, mazelen, shigella,
plasmodium falciparum
• Preventie: vermijden blootstelling, eradiceren reservoir en vector, vaccinatie, chemoprofylaxe

POTENTIEEL PATHOGENEN MICRO-ORGANISMEN
• Besmetting -> kolonisatie = dragerschap
• Commensale flora
• Infectie als
o Lokale of algemene voorbeschiktheid
§ Vb iv kathederinfectie door coagulase negatieve stafylokokken
§ Postoperatieve wondinfectie
§ Candida in de mond of vulvovaginaal: bij diabetica of na AB
o Micro-organismen krijgen toegang tot steriele lichaamscompartimenten vb e.coli in
de urine
• Endogene infectie: worden dus veroorzaakt door eigen flora
• Preventie: vermijden of corrigeren van voorbeschikkende gastheerfactoren en
hygiëne/asepsie in de zorg
• Nosocomiale infecties = verworven in het ziekenhuis
o Koloniserende micro-organismen die de pt verwerft tijdens ziekenhuisopname
o Kan evolueren naar ernstige infectie
o Vaak AB-resistent
o Preventie: vermijden voorbeschikkende gastheerfactoren, hygiëne/asepsie in de zorg,
bronisolatie

OPPORTUNISTISCHE MICRO-ORGANISMEN
• Besmetting -> kolonisatie bij gezonde personen
• Infectie enkel bij gastheer met ernstige stoornis in humorale of cellulaire afweermechanismen
• Exogeen, maar niet overdraagbaar tussen gezonde personen -> geen epidemies
• Pneumocystis jiroveci pneumonie bij AIDS pt, aspergillus pneumonie bij de langdurige
neutropene pt na chemotherapie

PATHOGENESE VAN INFECTIES

Noodzakelijk voor infectie: virulentiefactoren en inflammatoire respons van gastheer

VIRULENTIEFACTOREN VAN MICRO-ORGANISME
• Adherentie: stabiele binding van micro-organisme aan lichaamsoppervlak
• Proliferatie
• Exotoxines -> inflammatie en ziektesymptomen vb tetanospasmine van Clostridium tetani
• Invasief worden
1. Overschrijden huid- en mucosabarrière
2. Weerstandig aan afweermechanismen van gastheer (innate immunity)
3. Verspreiden in lichaam naar doelwitorganen


5

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Gnkkuleuven. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $13.52. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67096 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$13.52  8x  sold
  • (0)
  Add to cart